CytoDyn's Lead Product Candidate Leronlimab (PRO 140) Inhibits Colon Carcinoma Metastases to Liver and Lung in Preclinical Studies

Stock Information for CytoDyn Inc

Loading

Please wait while we load your information from QuoteMedia.